CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 355 enrolled
Drug / intervention
Chart reviewother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06561217
NCT06561217N/ACompleted
CompareCT.gov

Assessing the Performance of Artificial Intelligence (AI)-Augmented Electronic Health Record (EHR) Data Abstraction for Clinical Trial Patient Screening

University of Pennsylvania·observational·Posted Aug 19, 2024·Updated Jul 25, 2025

In Brief

An observational study evaluating Chart review for Cancer. Completed, enrolled 355 participants across 2 sites.

Detailed Summary

Identifying eligible patients is a key process in the clinical trial enterprise. Currently, this process relies on time-intensive manual chart review, creating a rate-limiting step for trial participation. The integration of AI technology into the trial screening process has potential to improve participation rates. This study aims to assess the performance (accuracy, efficiency) of AI-augmented patient identification and inform optimal integration into clinical research screening processes.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsCancer
CountriesUnited States
CollaboratorsMendel AI

Timeline

N/ACompletedFinished
202420252026
First PostedAug 19, 2024
Enrollment StartAug 18, 2023
Primary CompletionJul 12, 2024
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 1.9 years ago

Interventions

Chart reviewother

Chart review